These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37494866)

  • 21. Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D.
    Farid SS; Baron M; Stamatis C; Nie W; Coffman J
    MAbs; 2020; 12(1):1754999. PubMed ID: 32449439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technology outlook for real-time quality attribute and process parameter monitoring in biopharmaceutical development-A review.
    Wasalathanthri DP; Rehmann MS; Song Y; Gu Y; Mi L; Shao C; Chemmalil L; Lee J; Ghose S; Borys MC; Ding J; Li ZJ
    Biotechnol Bioeng; 2020 Oct; 117(10):3182-3198. PubMed ID: 32946122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enabling development, manufacturing, and regulatory approval of biotherapeutics through advances in mass spectrometry.
    Apostol I; Bondarenko PV; Ren D; Semin DJ; Wu CH; Zhang Z; Goudar CT
    Curr Opin Biotechnol; 2021 Oct; 71():206-215. PubMed ID: 34508981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.
    Qu M; An B; Shen S; Zhang M; Shen X; Duan X; Balthasar JP; Qu J
    Mass Spectrom Rev; 2017 Nov; 36(6):734-754. PubMed ID: 27097288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Technical advancement and practical considerations of LC-MS/MS-based methods for host cell protein identification and quantitation to support process development.
    Guo J; Kufer R; Li D; Wohlrab S; Greenwood-Goodwin M; Yang F
    MAbs; 2023; 15(1):2213365. PubMed ID: 37218066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward Higher QA: From Parametric Release of Sterile Parenteral Products to PAT for Other Pharmaceutical Dosage Forms.
    Hock SC; Constance NX; Wah CL
    PDA J Pharm Sci Technol; 2012; 66(4):371-91. PubMed ID: 22767885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring process-related impurities in biologics-host cell protein analysis.
    Pilely K; Johansen MR; Lund RR; Kofoed T; Jørgensen TK; Skriver L; Mørtz E
    Anal Bioanal Chem; 2022 Jan; 414(2):747-758. PubMed ID: 34595561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming nanomedicine manufacturing toward Quality by Design and microfluidics.
    Colombo S; Beck-Broichsitter M; Bøtker JP; Malmsten M; Rantanen J; Bohr A
    Adv Drug Deliv Rev; 2018 Mar; 128():115-131. PubMed ID: 29626549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applications of Raman Spectroscopy in Biopharmaceutical Manufacturing: A Short Review.
    Buckley K; Ryder AG
    Appl Spectrosc; 2017 Jun; 71(6):1085-1116. PubMed ID: 28534676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the role of current mass spectrometry in pharmaceutical analysis?
    Khalikova M; Jireš J; Horáček O; Douša M; Kučera R; Nováková L
    Mass Spectrom Rev; 2024; 43(3):560-609. PubMed ID: 37503656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automated Solid Phase Extraction (SPE) LC/NMR Applied to the Structural Analysis of Extractable Compounds from a Pharmaceutical Packaging Material of Construction.
    Norwood DL; Mullis JO; Davis M; Pennino S; Egert T; Gonnella NC
    PDA J Pharm Sci Technol; 2013; 67(3):267-87. PubMed ID: 23752753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated mass spectrometry multi-attribute method analyses for process development and characterization of mAbs.
    Song YE; Dubois H; Hoffmann M; D Eri S; Fromentin Y; Wiesner J; Pfenninger A; Clavier S; Pieper A; Duhau L; Roth U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Mar; 1166():122540. PubMed ID: 33545564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Fully Integrated Online Platform For Real Time Monitoring Of Multiple Product Quality Attributes In Biopharmaceutical Processes For Monoclonal Antibody Therapeutics.
    Liu Y; Zhang C; Chen J; Fernandez J; Vellala P; Kulkarni TA; Aguilar I; Ritz D; Lan K; Patel P; Liu A
    J Pharm Sci; 2022 Feb; 111(2):358-367. PubMed ID: 34534574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive multi-attribute method workflow for biotherapeutic characterization and current good manufacturing practices testing.
    Millán-Martín S; Jakes C; Carillo S; Rogers R; Ren D; Bones J
    Nat Protoc; 2023 Apr; 18(4):1056-1089. PubMed ID: 36526726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Process analytical technology (PAT) for biopharmaceutical products.
    Rathore AS; Bhambure R; Ghare V
    Anal Bioanal Chem; 2010 Sep; 398(1):137-54. PubMed ID: 20480150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing.
    Esmonde-White KA; Cuellar M; Lewis IR
    Anal Bioanal Chem; 2022 Jan; 414(2):969-991. PubMed ID: 34668998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current developments in LC-MS for pharmaceutical analysis.
    Beccaria M; Cabooter D
    Analyst; 2020 Feb; 145(4):1129-1157. PubMed ID: 31971527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-line product quality monitoring during biopharmaceutical manufacturing using computational Raman spectroscopy.
    Wang J; Chen J; Studts J; Wang G
    MAbs; 2023; 15(1):2220149. PubMed ID: 37288839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions.
    Szkodny AC; Lee KH
    Annu Rev Chem Biomol Eng; 2022 Jun; 13():141-165. PubMed ID: 35300518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.